Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cosmos Health (COSM) EBITDA Margin (2016 - 2025)

Cosmos Health's EBITDA Margin history spans 13 years, with the latest figure at 53.44% for Q4 2025.

  • Quarterly results put EBITDA Margin at 53.44% for Q4 2025, up 2552.0% from a year ago — trailing twelve months through Dec 2025 was 25.55% (up 1871.0% YoY), and the annual figure for FY2025 was 25.55%, up 1871.0%.
  • EBITDA Margin for Q4 2025 was 53.44% at Cosmos Health, down from 29.79% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 1.55% in Q1 2025 to a low of 303.88% in Q4 2022.
  • The 5-year median for EBITDA Margin is 27.47% (2025), against an average of 52.65%.
  • The sharpest move saw EBITDA Margin tumbled -24563bps in 2022, then surged 17892bps in 2023.
  • Year by year, EBITDA Margin stood at 58.25% in 2021, then tumbled by -422bps to 303.88% in 2022, then surged by 59bps to 124.97% in 2023, then surged by 37bps to 78.95% in 2024, then soared by 32bps to 53.44% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 53.44%, 29.79%, and 8.58% for Q4 2025, Q3 2025, and Q2 2025 respectively.